非增强乳腺MRI评估新辅助化疗后肿瘤体积变化
研究纳入2018年接受新辅助化疗的55例乳腺癌患者,比较最大强度投影弥散加权成像(MIP-DWI)与三维增强MRI评估肿瘤体积变化。肿块型病变ΔDWI与ΔCE的Spearman相关系数为0.89(p<0.01),非肿块强化为0.63(p<0.01);MIP-DWI处理时间显著短于3D-Ce-MRI(41.3±21.2 vs 199.5±98.3,p<0.01)。作者认为非增强乳腺MRI可适当且更快速地评估新辅助化疗后肿瘤体积变化,尤其对肿块型病变。
要点
- 肿块型病变ΔDWI与ΔCE的Spearman相关系数为0.89(p<0.01),非肿块强化为0.63(p<0.01)。
- MIP-DWI处理时间41.3±21.2显著短于3D-Ce-MRI的199.5±98.3(p<0.01)。
- 非增强乳腺MRI可适当且更快速评估新辅助化疗后肿瘤体积变化,尤其对肿块型病变。
核心结论
- 非增强乳腺MRI(MIP-DWI)能够适当且更快速地评估新辅助化疗后肿瘤体积变化,尤其对肿块型病变。
研究设计与样本
- 研究纳入2018年接受新辅助化疗的55例乳腺癌患者,使用SYNAPSE VINCENT®医学影像系统分析,比较MIP-DWI与3D-Ce-MRI评估的肿瘤体积变化及处理时间。
诊断标准与关键数值
- 肿块型病变ΔDWI与ΔCE的Spearman相关系数为0.89(p<0.01)。
- 非肿块强化病变ΔDWI与ΔCE的Spearman相关系数为0.63(p<0.01)。
- Time-DWI为41.3±21.2,Time-CE为199.5±98.3,Time-DWI显著短于Time-CE(p<0.01)。
临床应用与阅片要点
- 作者认为非增强乳腺MRI可适当且更快速地评估新辅助化疗后肿瘤体积变化,尤其对肿块型病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Three-dimensional contrast-enhanced magnetic resonance imaging (3D-Ce-MRI) is a most powerful tool for evaluation of neoadjuvant chemotherapy (NAC). However, the use of contrast agent is invasive, expensive, and time consuming, Thus, contrast agent-free imaging is preferable. We aimed to investigate the tumor volume change after NAC using maximum intensity projection diffusion-weighted image (MIP-DWI) and 3D-Ce-MRI.
METHOD: We finally enrolled 55 breast cancer patients who underwent NAC in 2018. All MRI analyses were performed using SYNAPSE VINCENT® medical imaging system (Fujifilm Medical, Tokyo, Japan). We evaluated the tumor volumes before, during, and after NAC. Tumor volume before NAC on 3D-Ce-MRI was termed Pre-CE and those during and after NAC were termed Post-CE. The observer raised the lower end of the window width until the tumor was clearly visible and then manually deleted the non-tumor tissues. A month thereafter, the same observer who was blinded to the 3D-Ce-MRI results randomly evaluated the tumor volumes (Pre-DWI and Post-DWI) using MIP-DWI with the same method. Tumor volume change between ΔCE (Pre-CE - Post-CE/Pre-CE) and ΔDWI (Pre-DWI - Post-DWI/Pre-DWI) and the processing time for both methods (Time-DWI and Time-CE) were compared.
RESULTS: We enrolled 55 patients. Spearman's rho between ΔDWI and ΔCE for pure mass lesions, and non-mass enhancement (NME) was 0.89 (p < 0.01), 0.63(p < 0.01) respectively. Time-DWI was significantly shorter than Time-CE (41.3 ± 21.2 and 199.5 ± 98.3 respectively, p < 0.01).
CONCLUSIONS: Non-contrast-enhanced Breast MRI enables appropriate and faster evaluation of tumor volume change after NAC than 3D-Ce-MRI especially for mass lesions.
引用
- Harada TL, Uematsu T, Nakashima K, et al. Non-contrast-enhanced breast MRI for evaluation of tumor volume change after neoadjuvant chemotherapy. Eur J Radiol. 2024. PMID: 38880053. doi:10.1016/j.ejrad.2024.111555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。